254 related articles for article (PubMed ID: 33358563)
21. Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients.
Montoya AM; Sánchez González A; Palma-Nicolás JP; Gómez-Treviño A; González JG; González GM
Med Mycol; 2015 Jun; 53(5):505-11. PubMed ID: 25980003
[TBL] [Abstract][Full Text] [Related]
22. First genotype identification of Trichosporon asahii in Sfax, Tunisia.
Sellami H; Trabelsi H; Neji S; Amouri I; Cheikhrouhou F; Makni F; Ayadi A
J Med Microbiol; 2017 Apr; 66(4):397-401. PubMed ID: 28141498
[TBL] [Abstract][Full Text] [Related]
23. Molecular Identification, Genotyping, Phenotyping, and Antifungal Susceptibilities of Medically Important Trichosporon, Apiotrichum, and Cutaneotrichosporon Species.
do Espírito Santo EPT; Monteiro RC; da Costa ARF; Marques-da-Silva SH
Mycopathologia; 2020 Apr; 185(2):307-317. PubMed ID: 31776790
[TBL] [Abstract][Full Text] [Related]
24. Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.
Mekha N; Sugita T; Ikeda R; Nishikawa A; Autthateinchai R; Poonwan N; Sawanpanyalert P
Mycopathologia; 2010 Jan; 169(1):67-70. PubMed ID: 19609716
[TBL] [Abstract][Full Text] [Related]
25. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
Tsai MS; Yang YL; Wang AH; Wang LS; Lu DC; Liou CH; Hsieh LY; Wu CJ; Cheng MF; Shi ZY; Lo HJ
Mycopathologia; 2012 Aug; 174(2):121-30. PubMed ID: 22318636
[TBL] [Abstract][Full Text] [Related]
26. Epidemiological investigation for grouped cases of Trichosporon asahii using whole genome and IGS1 sequencing.
Desnos-Ollivier M; Maufrais C; Pihet M; Aznar C; Dromer F;
Mycoses; 2020 Sep; 63(9):942-951. PubMed ID: 32506754
[TBL] [Abstract][Full Text] [Related]
27. Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
Antachopoulos C; Papakonstantinou E; Dotis J; Bibashi E; Tamiolaki M; Koliouskas D; Roilides E
J Pediatr Hematol Oncol; 2005 May; 27(5):283-5. PubMed ID: 15891566
[TBL] [Abstract][Full Text] [Related]
28. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients.
Kalkanci A; Sugita T; Arikan S; Yucesoy M; Ener B; Otag F; Kiraz N; Kustimur S; Sancak B; Evci C; Emektas G
Med Mycol; 2010 Feb; 48(1):141-6. PubMed ID: 19462333
[TBL] [Abstract][Full Text] [Related]
29. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.
Iturrieta-González IA; Padovan AC; Bizerra FC; Hahn RC; Colombo AL
PLoS One; 2014; 9(10):e109553. PubMed ID: 25360765
[TBL] [Abstract][Full Text] [Related]
30. Trichosporon asahii superinfections in critically ill COVID-19 patients overexposed to antimicrobials and corticosteroids.
Nobrega de Almeida J; Moreno L; Francisco EC; Noronha Marques G; Mendes AV; Barberino MG; Colombo AL
Mycoses; 2021 Aug; 64(8):817-822. PubMed ID: 34091966
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility patterns and molecular identification of Trichosporon species.
Rodriguez-Tudela JL; Diaz-Guerra TM; Mellado E; Cano V; Tapia C; Perkins A; Gomez-Lopez A; Rodero L; Cuenca-Estrella M
Antimicrob Agents Chemother; 2005 Oct; 49(10):4026-34. PubMed ID: 16189076
[TBL] [Abstract][Full Text] [Related]
32. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Araujo Ribeiro M; Alastruey-Izquierdo A; Gomez-Lopez A; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2008 Dec; 25(4):221-5. PubMed ID: 19071890
[TBL] [Abstract][Full Text] [Related]
33. Implication of efflux pumps and
Abbes S; Sellami H; Neji S; Trabelsi H; Makni F; Ayadi A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33688802
[No Abstract] [Full Text] [Related]
34. Genotyping, antifungal susceptibility testing, and biofilm formation of Trichosporon spp. isolated from urine samples in a University Hospital in Bangkok, Thailand.
Wongsuk T; Boonsilp S; Pumeesat P; Homkaew A; Sangsri T; Chongtrakool P
Acta Microbiol Immunol Hung; 2022 Sep; 69(3):247-257. PubMed ID: 35976734
[TBL] [Abstract][Full Text] [Related]
35. Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients.
Almeida AA; Crispim Bdo A; Grisolia AB; Svidzinski TI; Ortolani LG; Oliveira KM
Rev Argent Microbiol; 2016; 48(1):62-6. PubMed ID: 26916812
[TBL] [Abstract][Full Text] [Related]
36. Trichosporon asahii infection presenting as chronic meningo-ventriculitis and intra ventricular fungal ball: a case report and literature review.
Kumar A; Udayakumaran S; Babu R; Rajamma BM; Prakash A; Panikar D; Karim S; Chowdhary A
Mycoses; 2015 Feb; 58(2):99-103. PubMed ID: 25590228
[TBL] [Abstract][Full Text] [Related]
37.
Nobrega de Almeida J; Jimenez-Ortigosa C; Francisco EC; Colombo AL; Perlin DS
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0110122. PubMed ID: 36374073
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of isavuconazole against clinically relevant Trichosporon species: a comparative evaluation of EUCAST broth microdilution and MIC Test Strip methods.
Francisco EC; Dieleman C; Hagen F; Colombo AL;
J Antimicrob Chemother; 2023 Mar; 78(3):817-822. PubMed ID: 36702754
[TBL] [Abstract][Full Text] [Related]
39. Identification of the first isolates of Trichosporon asahii var asahii from disseminated trichosporonosis in China.
Abliz P; Fukushima K; Takizawa K; Yang R; Li R; Nishimura K
Diagn Microbiol Infect Dis; 2002 Sep; 44(1):17-22. PubMed ID: 12376026
[TBL] [Abstract][Full Text] [Related]
40. Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
Ramírez I; Moncada D
Mycopathologia; 2020 Apr; 185(2):377-388. PubMed ID: 31853871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
